NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Zoundream

Zoundream

Private
BaselHealthcare & Life Scienceshttps://zoundream.com/

Last Round

Seed

Oct 3, 2025

Total Funding Raised

$4.68M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Zoundream is a health-tech company that provides an AI-driven platform for infant cry analysis to translate needs and detect early signs of health conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Health IoT

Business Model

B2B2C

Customer Profile

Subscription SaaS, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

infant cry analysiscry translationbaby cry translatorvocal biomarkerneurodevelopmental disorder detectionearly pathology detectionbaby techsmart baby monitoracoustic analysisinfant health monitoringspeech development monitoringbaby monitor softwaredigital biomarkerhealth IoTB2B2C licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zoundream Comps

Public and private peers based on sector, stage, and business model.

Zoundream comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Zoundream Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 3, 2025

Key People

Founding team and executive leadership

Roberto Iannone

CEO & Co-Founder

Founding Team

Zoundream Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 16, 2026

    Grew 21% QoQ, from 19 to 23 employees.

  • Jan 20, 2026

    Grew 22% QoQ, from 18 to 22 employees.

Zoundream Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zoundream Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zoundream's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel
Employee Range23
Year Founded2018
Last FundingOct 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.